University of Chicago Visiting Professor Series: Current Indications for Charting a New Course in Blood Cancer Treatment with CAR T-Cell Therapy-November 2017
Target Audience
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Discuss the generation and regulation of anti-tumor immunity;
- Describe the biology and potential toxicities associated with CAR T-cell therapy;
- Summarize the current clinical data of CAR T-cell therapy in B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and B-cell Non-Hodgkin lymphomas;
- State how this current clinical data can improve patient care.
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Participation

Want to know more?
Click here to learn more about Cooper's Hawk Winery & Restaurant!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-573-9500 or via email at Brooke.Hernandez@uchospitals.edu.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
COURSE FACULTY
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with anycommercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Claiming Credit: Enter the access code to unlock the credit claiming process.